Spain· ES:09602002
SCINTIMUN 1 mg, EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA
A besilesomab product containing besilesomab, registered in Spain by Telix Innovations. The same ATC class is registered in 2 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Besilesomab is registered in 2 of 19 countries.
Countries holding a registration under ATC Besilesomab (besilesomab), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 1 of them publish a price we can compare per daily dose
Besilesomab · ATC Besilesomab
2 / 19 countries
- Spainprice
- United Kingdom
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- besilesomab
- Manufacturer
- Telix Innovations
- Country
- Spain (ES)
- ATC code
- Besilesomab
- ATC class
- Besilesomab
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Besilesomab in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSCINTIMUNTelix Innovations, Herstal
- BelgiumScintimun 1 mgTelix Innovations
- United KingdomScintimun 1mg kit for radiopharmaceutical preparationCurium Pharma UK Ltd
- PolandScintimunTelix Innovations
- SwedenScintimun 1 mg Beredningssats för radioaktivt läkemedelTelix Innovations
- SwitzerlandScintimun, Markierungsbesteckb.e.imaging.ag
- FinlandScintimunTelix Innovations
- FranceSCINTIMUN 1 mg trousse pour préparation radiopharmaceutiqueTELIX INNOVATIONS (BELGIQUE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scintimun
- Liechtenstein · Scintimun
- Norway · Scintimun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/242f80b8-48e0-4963-9cd8-b8bd3aee54eb GET /v1/drugs/242f80b8-48e0-4963-9cd8-b8bd3aee54eb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1273874400000}",
"nregistro": "09602002",
"substance": "besilesomab"
}See everything about besilesomab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.